← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
101	101 Benitec Biopharma BNTC $295M	21	+4	+24%	$2.6M
102	102 Estrella Immunopharma ESLA $23.3M	21	+2	+11%	$32.9M
103	103 Genprex GNPX $1.88M	21	-4	-16%	$10.8M
104	KRBP 104 DELISTED Kiromic BioPharma, Inc. Common Stock KRBP	20	0	0%	$1.73M
105	FRLN 105 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	19	+1	+6%	$21.3M
106	SCPS 106 DELISTED Scopus BioPharma Inc. Common Stock SCPS	19	-2	-10%	$693K
107	107 Creative Medical Technology CELZ $6.21M	14	+6	+75%	$735K
108	108 IN8bio INAB $11.7M	14	+1	+8%	$7.02M
109	LGVN 109 Longeveron LGVN $4.78M	13	-4	-24%	$9.59M
110	110 BioRestorative Therapies BRTX $2.02M	12	+2	+20%	$1.8M
111	CYAD 111 DELISTED Celyad Oncology SA American Depositary Shares CYAD	8	-2	-20%	$16.8M
112	112 Immix Biopharma IMMX $720M	8	-3	-27%	$352K
113	113 NewcelX Ltd NCEL $16.5M	5	-2	-29%	$102K
114	114 Genenta Science GNTA $32.3M	3	+1	+50%	$332K
115	TCBP 115 DELISTED TC BioPharm (Holdings) plc American Depositary Shares TCBP	1	+1	–	$399K
116	116 Artiva Biotherapeutics ARTV $296M	–	–	–	–
117	117 Coya Therapeutics COYA $102M	–	–	–	–
118	118 DELISTED CARGO Therapeutics CRGX	–	–	–	–
119	119 enGene Therapeutics ENGN $115M	–	–	–	–
120	120 FibroBiologics FBLG $7.08M	–	–	–	–
121	121 CytoMed Therapeutics GDTC $10.4M	–	–	–	–
122	GRML 122 Greenland Mines Ltd GRML $92.9M	–	–	–	–
123	123 Fractyl Health GUTS $55.2M	–	–	–	–
124	124 Kyverna Therapeutics KYTX $369M	–	–	–	–
125	125 Lexeo Therapeutics LXEO $227M	–	–	–	–